Charlotte, NC (www.aktiencheck.de) - Stryker-Aktienanalyse von Truist:Die Analysten von Truist passen ihr Kursziel für die Aktie von Stryker Corp. (ISIN:…
Stryker upgraded on strong execution and room for rebound…
Stryker zählt zu den Schwergewichten der Medizintechnik und profitiert von strukturellen Trends, die weit über konjunkturelle Schwankungen hinausreichen. Der Konzern…
AI is reshaping MedTech, and Stryker, Tempus AI and GE HealthCare are emerging as key players leveraging AI across surgery,…
Medical technology company Stryker last week announced the expansion of its Salt Lake City operations in a move the company…
Portage, Michigan, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared…
Image source: The Motley Fool.DATENov. 4, 2025 2:56 p.m. ETCALL PARTICIPANTSChairman, Chief Executive Officer, and President — R. Jeffrey BaillyChief…
San Francisco (www.aktiencheck.de) - Stryker-Aktienanalyse von Wells Fargo Advisors:Wells Fargo habe das Kursziel für die Aktie von Stryker Corp. (ISIN:…
Bernstein reiterates Outperform rating on Stryker stock, cites growth outlook…
The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended September 2025, but…
Strykers Q3 results top estimates with double-digit sales and profit growth, but shares slip as investors weigh tariff pressures despite…
Zacks highlights four GARP (Growth at a Reasonable Price) stocks Stryker, NVIDIA, ResMed, and Ralph Lauren combining strong growth prospects…
London (www.aktiencheck.de) - Stryker-Aktienanalyse von Rothschild & Co Redburn:Die Analysten von Rothschild & Co Redburn haben die Coverage der Aktie…
Portage, Michigan, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared…
Key PointsRevenue (GAAP) increased 11.1% to $6.0 billion, above analyst expectations.Adjusted earnings per share rose 11.4% to $3.13, exceeding consensus…
The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended June 2025, but…
Stryker (SYK) delivered earnings and revenue surprises of +2.29% and +1.09%, respectively, for the quarter ended June 2025. Do the…
Strykers second-quarter 2025 results are expected to reflect strong segmental performance. However, rising costs and tariffs are likely to have…
Stryker (SYK) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…
MA, VZ, SYK, ESP, and CHCI show strength across sectors, with solid growth, tech advances, and strategic positioning in 2025.…
Stryker secures FDA clearance for OptaBlate BVN, a groundbreaking nerve ablation system designed to treat chronic vertebrogenic lower back pain…
Portage, Michigan, May 08, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared…